Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Previous close
SAR 109.10
Day range
SAR 110.00 - SAR 111.40
Year range
SAR 108.00 - SAR 140.60
Market cap
2.21B SAR
Avg Volume
21.26K
P/E ratio
22.76
Dividend yield
2.12%
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 107.95M | 33.17% |
Operating expense | 51.48M | 31.26% |
Net income | 8.28M | 114.06% |
Net profit margin | 7.67 | 60.80% |
Earnings per share | — | — |
EBITDA | 13.78M | 111.63% |
Effective tax rate | 15.69% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.42M | 40.70% |
Total assets | 565.61M | 14.49% |
Total liabilities | 194.27M | 15.74% |
Total equity | 371.33M | — |
Shares outstanding | 20.00M | — |
Price to book | 5.88 | — |
Return on assets | 4.73% | — |
Return on capital | 6.06% | — |
Cash Flow
Net change in cash
| (SAR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 8.28M | 114.06% |
Cash from operations | 24.80M | 184.07% |
Cash from investing | -8.39M | -113.91% |
Cash from financing | -21.26M | -183.08% |
Net change in cash | -4.85M | 38.06% |
Free cash flow | 12.58M | 132.20% |
About
Founded
1998
Headquarters
Website
Employees
632
